Bills › 91st General Assembly
Relating to the controlled substance crystalline polymorph psilocybin. Vetoed 6-11-25
Sponsored by the House Health and Human Services Committee, Rep. Ann Meyer (R)
Where it is now
- Done: IntroducedJanuary 14, 2025
- Done: SubcommitteeJanuary 22, 2025
- Done: House committeeFebruary 11, 2025
- Done: Passes the HouseFebruary 20, 202592–0
- Done: Senate committeeApril 3, 2025
- Done: Passes the SenateApril 16, 202547–0
- Done: To the GovernorMay 19, 2025
- Stopped: VetoedJune 11, 2025
Vetoed What’s a funnel?
What’s in it
AI summary If the FDA approves a specific form of the drug psilocybin, this law would move it from a highly restricted category to a different one. Once this change happens, doctors could legally prescribe and sell the drug. This would change how the substance is handled and regulated in Iowa.1
Read the official explanation
This bill relates to the controlled substance crystalline polymorph psilocybin.201(4)(s)).204(4), a drug that contains the pharmaceutical composition of crystalline polymorph psilocybin shall be immediately removed from schedule I upon its approval by the United States food and drug administration and rescheduled based upon the recommendations of the United States food and drug administration and its listing in the federal Controlled Substances Act. The bill provides that upon the rescheduling of psilocybin, it shall be lawful to prescribe, distribute, and market the pharmaceutical composition of crystalline polymorph psilocybin. Current penalties for the possession of psilocybin range from a serious misdemeanor to a class “B” felony.
Senate subcommittee
Named March 3, 2025. On March 20, 2025 it recommended passage.
Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part
Family tree
Study bill
91st General Assembly